The results showed that the optimal dose to reduce NETs release in response to CAH or CAIY was 2.5 μM according to Lapponi et al. (2013), who consistently demonstrated that NF-κB inhibitor is able to inhibit both pNF-κB and NET induction. Here, NFKB1 is linked to congenital adrenal hyperplasia.